Adults 18 to 100, any sex, with Genetic Predisposition. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in Knowledge ScorePrimary· MMIC Survey administered within 7 days prior to and post-genetic counseling visit
Measure change in knowledge of basic principles of cancer genetics and implications of genetic testing for personal healthcare and relatives pre- and post- genetic counseling using the Multi-dimensional Model of Informed Choice (MMIC) scale knowledge score, with minimum and maximum scores of 0 and 8 respectively, and higher scores correlated with better knowledge
Group
Value
95% CI
In-person Genetic Counseling
0.05
± 1.37
Telephone Genetic Counseling
-0.08
± 1.51
Patient Reported Outcome of Patient SatisfactionPrimary· GCSS survey administered within 7 days post-genetic counseling visit
Measure patient-reported patient satisfaction with genetic counseling visit using the Genetic Counseling Satisfaction Scale (GCSS) scores, with minimum and maximum values of 6 and 30 respectively and higher scores correlated with higher satisfaction
Group
Value
95% CI
In-person Genetic Counseling
24.64
± 5.38
Telephone Genetic Counseling
25.27
± 3.75
Clinical Outcome Measure of Genetic Counseling Visit CompletionPrimary· Genetic counseling visit completion was evaluated daily, up to 13.5 months
Measure difference in genetic counseling visit completion rate between study arms
Group
Value
95% CI
In-person Genetic Counseling
141
Telephone Genetic Counseling
131
Patient Reported Outcome of Genetic Counseling-specific EmpowermentSecondary· GOS survey administered within 7 days prior to and post-genetic counseling visit
Measure change in patient reported genetic counseling-specific empowerment pre and post-genetic counseling using the Genomic Outcome Scale (GOS) scores with minimum and maximum scores of 6 and 30 respectively and higher scores correlated with improved outcomes
Group
Value
95% CI
In-person Genetic Counseling
-0.21
± 5.34
Telephone Genetic Counseling
0.86
± 4.62
Number of Participants That Made an Informed ChoiceSecondary· MMIC survey administered within 7 days post-genetic counseling and genetic testing uptake during scheduled genetic counseling appointment
Participants' ability to make an informed choice is assessed by the number of participants that made an informed choice using the Multi-dimensional Model of Informed Choice composite tool that includes understanding of relevant knowledge (1-8 items-higher scores indicate greater knowledge), attitudes toward testing (1-5 items-higher scores represent more positive attitudes), and whether the test decision is congruent with personal values (positive or negative about testing in relation to whether testing was accepted or declined).
Group
Value
95% CI
In-person Genetic Counseling
39
Telephone Genetic Counseling
53
Clinical Outcome Measure of Genetic Testing CompletionSecondary· Sample for testing provided within 45 days of visit without sample failure
Measure genetic test completion rate between study arms
Group
Value
95% CI
In-person Genetic Counseling
83
Telephone Genetic Counseling
20
In-person Genetic Counseling
0
Telephone Genetic Counseling
3
In-person Genetic Counseling
3
Telephone Genetic Counseling
40
In-person Genetic Counseling
0
Telephone Genetic Counseling
18
Sponsor's own description
This 2-arm prospective, randomized, controlled clinical trial compared outcomes of telephone genetic counseling (intervention) versus in-person genetic counseling (control) in an underserved, multilingual patient population referred for cancer genetic counseling at two North Texas safety-net hospitals.
The main question\[s\] it aims to answer are:
* Is telephone genetic counseling equal to in-person genetic counseling in the patient reported outcomes? Cancer genetics knowledge, attitude towards GT, and informed choice as well as GC-specific empowerment.
* Is telephone genetic counseling-based clinical outcomes the same as in-person genetic counseling for visit completion and testing rates? Participants will be randomized to either in-person or telephone genetic counseling arm and complete standard of care genetic counseling visit process where testing is offered. Both arms will complete a series of surveys to assess the outcomes of interest.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Other recruiting trials for Genetic Predisposition
Currently open trials in the same condition.
NCT06089421 — Genetic Information Assistant in Telegenetics
· NA
· recruiting
NCT06441942 — Prospective Multicenter Registry of Gender, Diversity and Inclusion (GEDI) of Women With Acute Coronary Syndrome
· recruiting
NCT06554288 — Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
· Phase 1
· recruiting
NCT06446271 — Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH)
· recruiting
NCT06377033 — Using the EHR to Advance Genomic Medicine Across a Diverse Health System
· NA
· recruiting
Other University of Texas Southwestern Medical Center trials
Trials by the same sponsor.
NCT03849963 — Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain
· recruiting
NCT06917183 — Developing Strategies for Implementation and Use of the Operating Room Black Box (ORBB)
· NA
· not yet recruiting
NCT05145309 — Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans
· Phase 2
· not yet recruiting
NCT06552000 — Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer
· NA
· not yet recruiting
NCT07387666 — Imaging Acetadote Metabolism in Glioblastoma
· EARLY_PHASE1
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas Southwestern Medical Center
Last refreshed: 6 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06212310.